Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Fighting skin cancer with a Patient's own supercharged immune cells
Disease control Recruiting nowThis study is testing a personalized cell therapy called lifileucel for people with advanced melanoma that has worsened after standard immunotherapy. Doctors take immune cells from a patient's tumor, grow large numbers of them in a lab, and infuse them back into the patient to at…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Personalized immune cell therapy tested for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is testing a personalized cell therapy called lifileucel for women with advanced endometrial cancer that has stopped responding to standard treatments like chemotherapy and immunotherapy. Doctors will collect a patient's own tumor-fighting immune cells, grow large numb…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Pronged attack on Tough-to-Treat skin cancer
Disease control Recruiting nowThis study is testing a new, modified drug called IOV-3001 in combination with a personalized cell therapy (lifileucel) for people with advanced melanoma that has spread or cannot be removed by surgery. The main goals are to find a safe dose and see how well the body handles the …
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Fighting lung cancer with a Patient's own supercharged immune cells
Disease control Recruiting nowThis study is testing a personalized treatment called LN-145 for people with metastatic non-small cell lung cancer that has worsened after standard therapy. Doctors take immune cells from a patient's own tumor, grow large numbers of them in a lab, and then infuse them back into t…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC